Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
givosiran
2
×
indiana blog main
indiana top stories
life sciences
m&a
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
2
×
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
2
×
wisconsin blog main
wisconsin top stories
2019
abbvie
activism
acute hepatic porphyria
akouos
allergan
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
What
bio
roundup
acquisitions
advanced
alnylam’s
announced
approval
bff
ceo
collabs
conference
covid
daniel
deal
deals
devoted
disease
drug
easl
form
gene
gilead
gilead’s
help
introduce
ipo
kicked
liver
major
medicines
month
o’day
plans
race
sciences
therapy
transformative
treat
updates
world's
Language
unset
Current search:
givosiran
×
" san diego top stories "
×
" texas top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More